Effect of remote ischaemic conditioning on platelet aggregation and platelet turnover
Remote ischaemic conditioning (RIC) is a new beneficial treatment for patients with ST-elevation myocardial infarction. RIC may inhibit thrombus formation and, therefore, we investigated whether RIC affects platelet aggregation and turnover. 30 healthy male volunteers were subjected to intervention on day 1 (sham intervention, no aspirin), day 2 (RIC, no aspirin), and day 16 (RIC, treated 7 days with aspirin 75 mg/day). RIC was performed as four cycles of 5 min interchangeable inflation and deflation using an automated cuff. Blood samples were collected 5 min before, as well as 5 and 45 min after RIC. Platelet aggregation was measured by Multiplate® using collagen (COLtest), adenosine diphosphate (ADPtest), and arachidonic acid (ASPItest) as agonists. Platelet turnover was evaluated by flow cytometry. Serum thromboxane B2 was determined by ELISA to confirm aspirin compliance. We found no significant change in platelet aggregation at visit 1 (COLtest: p = 0.32; ADPtest: p = 0.24; ASPItest: p = 0.07), visit 2, except for ADP-induced platelet aggregation evaluated 5 min after RIC (COLtest: p = 0.39; ADPtest: p = 0.02; ASPItest: p = 0.39), or visit 3 (COLtest: p = 0.48; ADPtest: p = 0.61; ASPItest: p = 0.90). Platelet turnover was not influenced by RIC, neither on nor off aspirin (all p-values > 0.07). (1) RIC did not affect platelet aggregation in healthy young men. (2) RIC did not affect platelet turnover in healthy young men. (3) Aspirin did not influence the effect of RIC on platelet aggregation and turnover. (4) Future studies exploring the effect of RIC on platelet aggregation and turnover in patients with ischaemic heart disease are warranted.
KeywordsAspirin Ischaemic conditioning Platelet aggregation Platelet function tests Platelet turnover
We wish to thank laboratory technicians Vivi Bo Mogensen and Mai Stenulm Veirup, Department of Clinical Biochemistry, Aarhus University Hospital, Denmark for laboratory assistance.
The study was supported by The Danish Heart Association, Independent Research Fund Denmark, A.P. Møller Foundation, Helge Peetz og Verner Peetz og hustru Vilma Peetz Foundation, Murermester Lauritz P. Christensen og hustru Kirsten S. Christensens Foundation, Snedkermester Sophus Jacobsen & hustru Astrid Jacobsen Foundation, and Fonden af 17-12-198. The funding sources had no influence on the study design, collection, analysis or interpretation of the data, writing of the manuscript, or the decision to submit the manuscript for publication.
Compliance with ethical standards
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
- 2.Bøtker HE, Kharbanda R, Schmidt MR, Bøttcher M, Kaltoft AK, Terkelsen CJ, Munk K, Andersen NH, Nielsen TT (2010) Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 375(9716):727–734. https://doi.org/10.1016/S0140-6736(09)62001-8 CrossRefPubMedGoogle Scholar
- 3.Sloth AD, Schmidt MR, Munk K, Kharbanda RK, Redington AN, Schmidt M, Pedersen L, Sørensen HT, Bøtker HE (2014) Improved long-term clinical outcomes in patients with ST-elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention. Eur Heart J 35(3):168–175. https://doi.org/10.1093/eurheartj/eht369 CrossRefPubMedGoogle Scholar
- 4.Meybohm P, Bein B, Brosteano B, Cremer J, Gruenewald M, Stoppe C, Coburn M, Schaette G, Zacharowski K, RIPHeart study collaborators, et al (2015) A multicenter trial of remote ischemic preconditioning for heart surgery. N Engl J Med 373(15):1397–1407. https://doi.org/10.1056/NEJMoa1413579 CrossRefPubMedGoogle Scholar
- 11.Pedersen CM, Cruden NL, Schmidt MR, Lau C, Bøtker HE, Kharbanda RK, Newby DE (2011) Remote ischemic preconditioning prevents systemic platelet activation associated with ischemia-reperfusion injury in humans. J Thromb Haemost 9(2):404–407. https://doi.org/10.1111/j.1538-7836.2010.04142.x CrossRefPubMedGoogle Scholar
- 19.Pryds K, Kristiansen J, Neergaard-Petersen S, Nielsen RR, Schmidt MR, Refsgaard J, Kristensen SD, Bøtker HE, Grove EL et al (2017) Effect of long-term remote ischaemic conditioning on platelet function and fibrinolysis in patients with chronic ischaemic heart failure. Thromb Res 153:40–46. https://doi.org/10.1016/j.thromres.2017.03.008 CrossRefPubMedGoogle Scholar
- 20.Grove EL, Hvas AM, Johnsen HL, Hedegaard SS, Pedersen SB, Mortensen J, Kristensen SD (2010) A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease. J Thromb Haemost 103(6):1245–1253. https://doi.org/10.1160/TH09-08-0527 CrossRefGoogle Scholar
- 23.Weber NC, Riedemann I, Smit KF, Zitta K, van de Vondervoort D, Zuurbier CJ, Hollmann MW, Preckel B, Albrecht M (2015) Plasma from human volunteers subjected to remote ischemic preconditioning protects human endothelial cells from hypoxia-induced cell damage. Basic Res Card 110(2):17. https://doi.org/10.1007/s00395-015-0474-9 CrossRefGoogle Scholar